Thursday, December 17, 2009

Drug rep RIP

1 comment:

Anonymous said...

Yes, this trend gets even more interesting when you overlay access to doctors and the rise of generic market share, especially in the US.

We noticed these trends back in September while doing a consulting project and it was most instructive to see the big industry picture.